Clinical Trial Update: ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA [Phase 2]

View source ↗

Summary

Phase 2 trial results update for elamipretide in age-related macular degeneration with non-central geographic atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2023-10-17